Director of National Intelligence Tulsi Gabbard just did something the political class promised us they had already investigated: she declassified a packet of ODNI slides that lays out U.S. funding and support for biological research labs around the world — including more than 40 sites in Ukraine. The documents are short, stark, and stamped “DECLASSIFIED by DNI GABBARD.” Whether you’re worried about transparency, national security, or plain common sense, this matters.
What the ODNI declassification actually shows
The ODNI press release and the slide packet make a straightforward claim: U.S. government funding and support were tied to more than 120 biological laboratories in over 30 countries, and the slides list over 40 labs in Ukraine that were “built and supported.” The slides name contractors, even cite per‑lab figures in some cases, and list pathogens of concern — anthrax, tularemia, tuberculosis, MERS, SARS, Marburg, Ebola, Lassa, plague, Rickettsia, and others. Those are not sugarcoated words in a rumor mill; they are text on declassified slides approved for public release.
Why the establishment is squealing — and why that matters
Notice how quickly some officials and pundits reverted to the old line: “That’s Kremlin propaganda.” Funny — the documents aren’t from a Russian state outlet. They came from the Office of the Director of National Intelligence, rolled out with a public press release. If the professional class was so sure two years ago, why is a DNI now clearing slides that say otherwise? This isn’t just about politics. It’s about trust. We deserve answers about who paid for what, why certain pathogens were listed, and whether any of the work went beyond diagnostics and public‑health surveillance.
Not proof of a bioweapons program — but big unresolved questions
Let’s be clear: funding a lab or providing training and equipment does not automatically equal a biological‑weapons program. Longstanding U.S. threat‑reduction and bioengagement programs have helped upgrade partner-country labs for diagnostics and biosurveillance for decades. Ukraine’s health and foreign ministries insist the labs were civilian and focused on public‑health work, and experts rightly note that the slides don’t, by themselves, prove illicit activity. But the slides raise real, narrow questions that cannot be waved away with cheap labels. Why were specific pathogens listed? Which contractors did what? Do the contracts include experimental protocols or just equipment and training? Those are factual questions that deserve straight answers.
What should happen next — transparency and oversight, not spin
Start with the basics: publish the underlying contracts, grant records, and lab protocols tied to the facilities named. Congress should demand full briefings and, if necessary, launch oversight hearings. The IGs at relevant agencies should get copies and examine whether rules were followed. Independent scientific reviewers should assess whether the work described was consistent with routine diagnostics and biosurveillance or something else. We can all agree on one thing — secrecy breeds suspicion. If this was all aboveboard, then release the paperwork and shut down the conspiracy talk. If not, hold people accountable. Either path is better than dodging questions while the public pays the tab and worries about risks.

